Related Experiment Video
Updated: May 21, 2026
08:19
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Review article: Improving mitochondrial function: Current therapeutic perspectives in neurodegenerative diseases
Julia Brechtel1, Christine Lietz1, Selin Akpinar Adscheid1
1Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-Universität Mainz (JGU), Mainz, Germany.
Pharmacological Research
|May 19, 2026
Summary
Mitochondrial dysfunction drives neurodegeneration and aging. Therapies targeting mitochondria, like phytochemicals and novel approaches, show promise for treating these conditions.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial dysfunction is a central factor in neurodegenerative diseases and aging.
- Key issues include impaired energy production, oxidative stress, and disrupted mitophagy and biogenesis.
- Mitochondria's role in bioenergetics, redox balance, and neuronal survival makes them therapeutic targets.
Purpose of the Study:
- To review mechanisms of mitochondrial function and failure in neurodegeneration.
- To link mitochondrial issues to Alzheimer's and Parkinson's disease.
- To summarize evidence for therapeutic strategies targeting mitochondria.
Main Methods:
- Literature review of preclinical studies on phytochemicals and mitochondria-targeted small molecules.
- Analysis of lifestyle interventions.
- Examination of emerging therapeutic technologies like nanoparticles, mtDNA editing, and mitochondrial transfer.
Main Results:
- Phytochemicals and small molecules can enhance mitochondrial biogenesis, mitophagy, respiratory efficiency, and antioxidant defense in preclinical models.
- Many compounds show preventive rather than restorative effects, with limited clinical evidence.
- Next-generation approaches indicate significant future therapeutic potential.
Conclusions:
- Mitochondria-directed therapies offer potential disease-modifying or preventive strategies for neurodegenerative disorders.
- Future success depends on improved delivery methods, synergistic combinations, and robust clinical trials.
- Restoring mitochondrial integrity is a key goal for combating neurodegeneration and aging.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:28The Inner Mitochondrial Membrane
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...